Comparison between Infinium Pharmachem IPO and Labelkraft Technologies IPO.
Infinium Pharmachem IPO is a SME Fixed Price IPO proposed to list at NSE SME while Labelkraft Technologies IPO is a SME Fixed Price proposed to list at BSE SME.
| Infinium Pharmachem IPO | Labelkraft Technologies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Swastika Investmart Ltd. | Hem Securities Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Swastika Investmart Ltd. | Hem Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Infinium Pharmachem IPO is up to ₹23.99 Cr whereas the issue size of the Labelkraft Technologies IPO is up to ₹4.51 Cr. The final issue price of Infinium Pharmachem IPO is ₹135.00 per share and of Labelkraft Technologies IPO is ₹55.00 per share.
| Infinium Pharmachem IPO | Labelkraft Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹135.00 per share | ₹55.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹13.50 per share | |
| Market Lot Size | 1000 shares | 2000 shares |
| Fresh Issue Size | 17,81,000 shares | 8,20,000 shares |
| Fresh Issue Size (Amount) | up to ₹23.99 Cr | up to ₹4.51 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,81,000 shares | 8,20,000 shares |
| Issue Size Total (Amount) | up to ₹23.99 Cr | up to ₹4.51 Cr |
Infinium Pharmachem IPO opens on Mar 31, 2023, while Labelkraft Technologies IPO opens on Mar 13, 2023. The closing date of Infinium Pharmachem IPO and Labelkraft Technologies IPO is Apr 05, 2023, and Mar 15, 2023, respectively.
| Infinium Pharmachem IPO | Labelkraft Technologies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 31, 2023 | Mar 13, 2023 |
| Issue Close | Apr 05, 2023 | Mar 15, 2023 |
| Basis Of Allotment (Tentative) | Apr 11, 2023 | Mar 20, 2023 |
| Initiation of Refunds (Tentative) | Apr 12, 2023 | Mar 21, 2023 |
| Credit of Share (Tentative) | Apr 13, 2023 | Mar 22, 2023 |
| Listing date (Tentative) | Apr 17, 2023 | Mar 23, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Infinium Pharmachem IPO P/E ratio is 7.83, as compared to Labelkraft Technologies IPO P/E ratio of 62.5.
| Infinium Pharmachem IPO | Labelkraft Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 99.71 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.05 | 73.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 7.83 | 62.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹93.93 Cr. | ₹17.84 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 43.85 | 45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 72 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.91 | 7.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹54.13 | ₹0.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 46.61 | 45.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Infinium Pharmachem IPO Retail Individual Investors (RII) are offered 8,70,000 shares while in Labelkraft Technologies IPO retail investors are offered 8,70,000 shares. Qualified Institutional Buyers (QIB) are offered in Infinium Pharmachem IPO and in Labelkraft Technologies IPO.
| Infinium Pharmachem IPO | Labelkraft Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 94,000 shares | 44,000 shares |
| QIB | ||
| NII | 8,70,000 shares | 4,10,000 shares |
| RII | 8,70,000 shares | 4,10,000 shares |
| Employee | 41,000 shares | |
| Others | ||
| Total | 17,81,000 shares | 8,20,000 shares |
Infinium Pharmachem IPO subscribed 1.92x in total, whereas Labelkraft Technologies IPO subscribed 53.42x.
| Infinium Pharmachem IPO | Labelkraft Technologies IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.94x | 46.84x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.00x | 59.84x |
| Employee (times) | 1.29x | |
| Other (times) | ||
| Total (times) | 1.92x | 53.42x |
